US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 48.170
  • -3.470-6.72%
Close Jun 14 16:00 ET
  • 50.740
  • +2.570+5.34%
Post 19:57 ET
2.68BMarket Cap-22992P/E (TTM)

About Structure Therapeutics Company

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Company Profile

SymbolGPCR
Company NameStructure Therapeutics
Listing DateFeb 3, 2023
Issue Price15.00
Founded2019
CEOProfessor Raymond C. Stevens, PhD
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address601 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-457-1978
Websitehttp://www.structuretx.com

Company Executives

  • Name
  • Position
  • Salary
  • Professor Raymond C. Stevens, PhD
  • Director and Chief Executive Officer
  • 747.33K
  • Melita Sun Jung
  • Chief Business Officer
  • --
  • Dr. Mark Bach, M.D.,PhD
  • Chief Medical Officer
  • 628.37K
  • Jun Yoon
  • Principal Accounting Officer, Director and Chief Financial Officer
  • --
  • Dr. Yingli Ma, PhD
  • Chief Technology Officer
  • 1.24M
  • Dr. Xichen Lin, PhD
  • Chief Scientific Officer
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • 2.42M
  • Dr. Ted W. Love, M.D.
  • Independent Director
  • --
  • Dr. Ramy Farid, PhD
  • Independent Director
  • --
  • Dr. Joanne Waldstreicher, M.D.
  • Independent Director
  • 218.82K
  • Sharon E. Tetlow
  • Independent Director
  • 213.84K
  • Eric L. Dobmeier
  • Independent Director
  • 218.82K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Weight Loss Drugs
Weight Loss Drugs
Intraday-0.30%